Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Fish and Richardson
Accenture
Harvard Business School
Covington
Johnson and Johnson

Generated: June 24, 2019

DrugPatentWatch Database Preview

Durvalumab - Biologic Drug Details

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for durvalumab
Tradenames:1
Patents:19
Applicants:1
BLAs:1
Suppliers: see list1

US Patents for durvalumab

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Astrazeneca Uk Ltd IMFINZI durvalumab INJECTABLE;INJECTION 761069 001 2017-05-01 ➤ Try a Free Trial Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC) ➤ Try a Free Trial RX search
Astrazeneca Uk Ltd IMFINZI durvalumab INJECTABLE;INJECTION 761069 001 2017-05-01 ➤ Try a Free Trial Flexus Biosciences, Inc. (Princeton, NJ) ➤ Try a Free Trial RX search
Astrazeneca Uk Ltd IMFINZI durvalumab INJECTABLE;INJECTION 761069 001 2017-05-01 ➤ Try a Free Trial ModernaTX, Inc. (Cambridge, MA) ➤ Try a Free Trial RX search
Astrazeneca Uk Ltd IMFINZI durvalumab INJECTABLE;INJECTION 761069 001 2017-05-01 ➤ Try a Free Trial ModernaTX, Inc. (Cambridge, MA) ➤ Try a Free Trial RX search
Astrazeneca Uk Ltd IMFINZI durvalumab INJECTABLE;INJECTION 761069 001 2017-05-01 ➤ Try a Free Trial Plexxikon Inc. (Berkeley, CA) ➤ Try a Free Trial RX search
Astrazeneca Uk Ltd IMFINZI durvalumab INJECTABLE;INJECTION 761069 001 2017-05-01 ➤ Try a Free Trial Immunomedics, Inc. (Morris Plains, NJ) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Fish and Richardson
Medtronic
Citi
McKesson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.